Chemical Name: 8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane Bromide;8-Aza-5-azoniaspiro[4.5]decane, 8-(2,3-dichlorophenyl)-, bromide (9CI)8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane bromide (1:1)
Smiles: ClC1=CC=CC(N2CC[N+]3(CCCC3)CC2)=C1Cl.[Br-]
Inchi: InChI=1S/C24H30Cl4N4/c25-19-5-3-7-21(23(19)27)31-15-11-29(12-16-31)9-1-2-10-30-13-17-32(18-14-30)22-8-4-6-20(26)24(22)28/h3-8H,1-2,9-18H2
Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and In vivo studies
Haley McFall1 , Sandeep Sarabu1 , Vijaykumar Shankar1 , Suresh Bandari1 , S. Narasimha Murthy1 , Karl Kolter2 , Nigel Langley3 , Dong Wuk Kim4**, Michael A. Repka
International Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311
Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole
Carmen Klein Herenbrink, Ravi Verma, Herman D Lim, Anitha Kopinathan, Alastair Keen, Jeremy Shonberg, Christopher J. Draper-Joyce, Peter J. Scammells, Arthur Christopoulos, Jonathan A Javitch, Ben Capuano, Lei Shi, and J Robert Lane
ACS Chem. Biol. 2019, 14, 8, 1780–1792
Identification of Degradation Impurities in Aripiprazole Oral Solution Using LC-MS and Development of Validated Stability Indicating Method for Assay and Content of Two Preservatives by RP-HPLC
M. V. V. N. Murali Krishna, Sumathi V. Rao & N. V. S. Venugopal
European Journal of Chemistry 2010, 1(1), 20-27
Development of stability indicating, validated HPLC method for quantitative determination of Aripiprazole and its impurities
Nandini R. Pai*, Deepnandan S. Dubhashi
Der Pharmacia Lettre, 2010, 2(4): 1-10